Relay Therapeutics RLAY
NASDAQ RLAY
$18.49 +0.44 (+2.44%)
At close: Oct 1, 2026 · 4:00 PM EDT

Relay Therapeutics (RLAY) Cash from Financing Activities (2019 - 2026)

Updated

Relay Therapeutics (RLAY) posted Cash from Financing Activities of $323.74 million for Q2 2026, up 133.3% from the prior quarter.

Analysis

Relay Therapeutics (RLAY) Cash from Financing Activities (2019 - 2026) Analysis & Trends

For the trailing twelve months through Jun 30, 2026, Cash from Financing Activities at Relay Therapeutics was $463.47 million; for FY2025, it came in at $1.6 million, down 99.4% from FY2024.

  • Annual Cash from Financing Activities shows a five-year compound annual growth rate of -67.3% (FY2020 to FY2025).
  • In prior years, Relay Therapeutics' Cash from Financing Activities was $270.15 million in FY2024 (+677.4%), $34.75 million in FY2023 (-88.0%), $289.91 million in FY2022 (-25.3%) and $388.09 million in FY2021 (-9.0%).
  • The Q2 2026 figure stands as the highest quarterly Cash from Financing Activities since Q4 2021.
  • The strongest year-over-year quarter for Cash from Financing Activities in the past five years was Q2 2022, with growth of 78.1%; the weakest was Q3 2025, with a decline of 100.0%.
  • According to Business Quant data, Cash from Financing Activities for the three prior quarters was $138.78 million (Q1 2026), $934,000 (Q4 2025) and $17,000 (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Financing (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn -8.78 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn -5.05 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn 1.76 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn -2.02 Bn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn -47.00 Mn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn -1.48 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn 2.34 Bn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn -3.66 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn -426.70 Mn
10 Relay Therapeutics 3.94 Bn 3.94 Bn - 323.74 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 323.74 Mn
Mar 31, 2026 138.78 Mn
Dec 31, 2025 934,000.00
Sep 30, 2025 17,000.00
Dec 31, 2024 800,000.00
Sep 30, 2024 218.89 Mn
Jun 30, 2024 1.54 Mn
Mar 31, 2024 48.92 Mn
Dec 31, 2023 21.92 Mn
Sep 30, 2023 9.46 Mn
Jun 30, 2023 2.08 Mn
Mar 31, 2023 1.30 Mn
Dec 31, 2022 1.17 Mn
Sep 30, 2022 285.87 Mn
Jun 30, 2022 2.00 Mn
Mar 31, 2022 883,000.00
Dec 31, 2021 384.01 Mn
Sep 30, 2021 902,000.00
Jun 30, 2021 1.12 Mn
Mar 31, 2021 2.06 Mn
API Access

Relay Therapeutics Cash from Financing Activities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=cash-from-financing-activities&ticker=RLAY&period=max&api_key=YOUR_API_KEY